Diagnostic and Pathological Markers in Human Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 15
Special Issue Editors
Interests: cancer; tumor blood biomarker screening and early diagnosis
Interests: clinical diagnosis; diagnostic markers; diagnostic models
Special Issue Information
Dear Colleagues,
Given the important role of tumor-related biomarkers in early diagnosis and pathological analysis of cancer patients, we are pleased to invite you to submit your research work on the latest advancements in biomarkers that aid in the early detection, prognosis and prediction of treatment response in various cancer types. We encourage contributions on both established and novel markers, including those involved in genetic mutations, protein expression, epigenetic changes and immune response. Topics may cover but are not limited to the following: molecular biomarkers for early cancer detection, tumor microenvironment and immune biomarkers, genomic alterations in cancer and liquid biopsy applications. Submissions should highlight innovative methodologies and translational research that demonstrate the potential impact of these markers in clinical practice. Contributions will play a crucial role in advancing cancer diagnostics, improving patient outcomes and fostering the development of personalized therapies.
This Special Issue aims to explore the evolving landscape of cancer diagnostics through the identification and validation of molecular markers that enhance our understanding of cancer pathogenesis. We welcome both original research articles and review papers that address these critical issues.
We look forward to receiving your contributions.
Dr. Zuoren Yu
Dr. Shengqiong Deng
Dr. Qian Zhao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- biomarker
- early diagnosis
- pathological markers
- prognostic model
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
